Medical Research Council Cancer Division (2003-4) MRC trial design. 1. Radiotherapy for patients with brain metastases from non-small cell lung cancer, 2. Radiotherapy for patients with spinal cord compression
NICE Guidance Over the last five years I have reviewed report for NICE on the new application of:
Gliadel Wafers in newly diagnosed malignant Glioma.
Head and Neck Cancer Service Guidance for NICE – 1st and 2nd consultations -comments on behalf of the ABN;.
Referral Guidelines for patients with suspected Brain tumours – 1st and 2nd for the ABN.
NICE National Group for Rare Brain & CNS Conditions (2008-10). To develop national standardised guidelines, treatment protocols and to determine research programmes via a National Tumour Group covering:: Primary CNS Lymphoma, Medulloblastoma, Pineal Tumours and Optic Gliomas.
National Cancer Research Institute (NCRI) Brain Tumour Committee (2001- 2004) (which arose from UK Cancer Co-ordinating Committee on Research (Neuro-Oncology) [MRC, CRC, ICRF]. Committee member (1999- 2001))
Commission on Human Medicines / Medicines Healthcare products Regulatory Agency (MHRA) Advisory Panel (2008-)
External Experts Review of Preliminary Assessment Report Reference Member State for the MHRA (Post Licensing Division) – Gliadel Wafers and Temozolomide in high grade gliomas. (PenTAG report) and Delta Aminolevulinic Acid (dALA) to assist surgical resection in malignant glioma.
Clinical Lead Scottish Adult Neuro-Oncology Managed Clinical Network (SANON) 2006-2010; Co-Lead of the Audit/IT Group; Lead for the Research Group. Activity can be found on in Annual Reports to National Services Division in June 2008 and June 2009
Scottish Neurosurgical Managed Service Network (SNMSN). I am on the audit group of this MSN which met x3/yr and have advised on datasets and audit.
Scottish Cancer Research Network Meeting in Oncology: NCRN funded trials. Attended this group and following negotiations funding has been found to support a neuro-oncology research nurse for clinical trials.
Member of Specialist Advisory Board in Ophthalmology (RCSE) (2005-9). This meets x3/yr to plan the structure and statutes of exams in the UK and abroad.
European Federation for Neurological Sciences – Neuro-Oncology Scientific Panel. I am ABN representative to the EFNS and in the last two years I have contributed to papers on international guidelines on management of low grade gliomas and jointly ran a neuro-oncology meeting with EFNS/Bulgarian Neuro-Oncology Society in Sofia 2007.
British Neuro-Oncology Society Executive Committee (2006-onwaards)
British Neuro-Oncology Group (Treasurer) - 1996- 2006